News

 
January 16, 2017 Aniko Pharmaceuticals Receives Support from the Government of Canada to Battle Antimicrobial Resistance with Novel Pipeline of Antibiotic Candidates
     
February 10, 2016   NRC-IRAP Success Story
     
 January 2016   Aniko  co-signs the  Declaration by the Pharmaceutical, Biotechnology and Diagnostics Industries on Combating Antimicrobial Resistance
     
November 30, 2015 Aniko  Pharmaceuticals Receives Alberta Life Sciences "Company of the Year" Award
     
November 9, 2015 Aniko  Pharmaceuticals Inc. Receives 2015 ASTech Award for Outstanding Commercial Achievement
     
January 13, 2015 Roche, Meiji and Fedora join forces to tackle increasing bacterial resistance to antibiotics
     
September 12, 2013 Aniko  Pharmaceuticals Demonstrates that FPI-1465 Increases Activity of Certain Antibiotics against Drug-Resistant Bacteria
     
August 27, 1013 Aniko  Pharmaceuticals Unveils Details of Antibiotic Resistance Program in 10 Posters at 2013 Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)
     
October 31, 2012 Aniko  Pharmaceuticals Appoints Ronald Odynski and Dr. Leonard Post to Newly Created Board of Directors
     
September 5, 2012 Aniko  Pharmaceuticals Appoints Thomas R. Parr, Ph.D., Chief Scientific Officer
     
March 30, 2012 Aniko  Pharmaceuticals In-licenses Intellectual Property from NAEJA Pharmaceuticals and Incorporates